
San Francisco-Early treatment at high-risk threshold reduces the rate of unfavorable acuity and structural outcomes in infants with retinopathy of prematurity (ROP), according to William V. Good, MD. Reporting new findings from the Early Treatment for Retinopathy of Prematurity Study (ETROP), Dr. Good added that systemic side effects are more common with earlier treatment but can be managed in the nursery.